
Current Securities Class Action Lawsuits
Open cases. Fast deadlines. See if you are eligible.
Didn’t Find Your Case? It may already be settled.
Browse settlements to see if yours qualifies.
WHAT'S NEW
Active Case![ImmunityBio, Inc. [IBRX] Securities Class Action Lawsuit Update](https://media.suewallst.com/cms-dev/IBRX_b3f81bce77.png)
![ImmunityBio, Inc. [IBRX] Securities Class Action Lawsuit Update](https://media.suewallst.com/cms-dev/IBRX_b3f81bce77.png)
ImmunityBio, Inc. [IBRX] Securities Class Action Lawsuit Update
ImmunityBio, Inc. (IBRX) faces a class action alleging it misled investors by overstating Anktiva’s cancer treatment potential and approved uses, following an FDA warning letter and stock decline.

Missing Numbers, Broken Trust: What Investors Need to Know
BREAKING: Wall Street execs shocked to discover that “trust” is not a legal defense. When the numbers go missing, it’s Main Street that pays the price. Know the signs. Know your rights.
